Baralyme Agreement (Tables)

9 Months Ended

Mar. 31, 2014

Deferred Revenue Disclosure [Abstract]

Deferred Revenue, by Arrangement, Disclosure [Table Text Block]

A reconciliation of deferred revenue resulting from the agreement with Abbott Laboratories (“Abbott”), with the amounts received under the agreement, and amounts recognized as net sales is as follows:

	Three Months ended				Nine Months ended
	March 31,				March 31,
	2014		2013		2014		2013
Beginning balance	$	-	$	-	$	-	$	114,700
Revenue recognized as net sales		0		0		0		(114,700)
		0		0		0		0
Less - Current portion of deferred revenue		0		0		0		0
	$	0	$	0	$	0	$	0